Asia Green Biotechnology Corp.
ASIA
Asia Green Biotechnology Corp. is an emerging international biotechnology firm... Asia Green Biotechnology Corp. is an emerging international biotechnology firm dedicated to researching, developing, testing, and distributing products. These offerings leverage the company's proprietary organic hybridization technology, with its primary application focused in Asia. A key aspect of their operations involves the cultivation and harvesting of novel and commercially valuable strains of hemp and similar crops. The company has forged strategic alliances with Pathway Rx Inc. and PNW Biosciences Inc. to advance the clinical development and market introduction of specific Cannabis sativa varieties. These varieties are being explored for their potential in both preventing and treating COVID-19 and other infectious ailments. Established in 2017, the organization was originally named Asia Cannabis Corp. It adopted its current moniker, Asia Green Biotechnology Corp., in April 2020. Its corporate headquarters are located in Calgary, Canada.
